| Bioactivity | NHS-MMAF is a modified MMAF extracted from patent WO2012143499, intermediat 219. MMAF is a potent tubulin polymerization inhibitor and is used as a antitumor agent[1] |
| Invitro | NHS-MMAF is a modified MMAF[1] |
| Name | NHS-MMAF |
| CAS | 1404073-19-3 |
| Formula | C49H78N6O12 |
| Molar Mass | 943.18 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. WO2012143499 |
NHS-MMAF
CAS: 1404073-19-3 F: C49H78N6O12 W: 943.18
NHS-MMAF is a modified MMAF extracted from patent WO2012143499, intermediat 219. MMAF is a potent tubulin polymerization
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.